|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and marketable securities | ||||||||||||||||||||
| Accounts receivable, net of allowance of $251,414 and $167,411, respectively | ||||||||||||||||||||
| Supplies inventory | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Investments in unconsolidated affiliates | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current income taxes payable | ||||||||||||||||||||
| Accrued salaries and benefits | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of deferred financing costs of $40,768 and $47,174, respectively | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Noncontrolling interests – redeemable | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock, no par value, 5,000 shares authorized, 1,725 shares issued and outstanding | ||||||||||||||||||||
| Common stock, no par value, 120,000 shares authorized, 54,804 and 54,294 shares issued and outstanding, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total AmSurg Corp. equity | ||||||||||||||||||||
| Noncontrolling interests – non-redeemable | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
